Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.43 |
| ▸ | MDM4 | O15151 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29408465 | 1.00 | KMT2A (0.55) | KMT2AEPHX2CASP3CTRB1MDM4 | |
| SCHEMBL20369405 | 1.00 | KMT2A (0.55) | KMT2AEPHX2CASP3CTRB1MDM4 | |
| SCHEMBL24305580 | 0.89 | KMT2A (0.50) | KMT2AEPHX2CASP3MDM4TP53 | |
| SCHEMBL29426426 | 0.89 | KMT2A (0.50) | KMT2AEPHX2CASP3MDM4TP53 | |
| SCHEMBL19080574 | 0.83 | KMT2A (0.59) | KMT2AEPHX2CASP3MDM4TP53 | |
| SCHEMBL1769671 | 0.83 | MDM4 (0.55) | KMT2AEPHX2CASP3MDM4TP53 | |
| SCHEMBL1486272 | 0.83 | MDM4 (0.55) | KMT2AEPHX2CASP3MDM4TP53 | |
| SCHEMBL29367928 | 0.83 | MDM4 (0.55) | KMT2AEPHX2CASP3MDM4TP53 | |
| SCHEMBL29367649 | 0.83 | MDM4 (0.55) | KMT2AEPHX2CASP3MDM4TP53 | |
| SCHEMBL30977663 | 0.83 | MDM4 (0.55) | KMT2AEPHX2CASP3MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017007695-A1 | MU OPIOID RECEPTOR MODULATORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-01-12 | — | — | WO | disclosed |